0920-21BL Annual OD2A TA Survey

Division of Overdose Prevention Technical Assistance Hub

Attachment 4. Annual OD2A Technical Assistance Survey

Form Approved

OMB No. 0920-XXXX

Exp. Date: XX-XX-XXXX

Public reporting burden of this collection of information is estimated to average 13 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; Attn: OMB-PRA (0920-New)

overdose data to action (OD2A) ANNUAL Technical Assistance (TA) Survey

Introduction

ICF, under contract with the Center for Disease Control (CDC), manages and evaluates the Overdose Data to Action (OD2A) technical assistance (TA).This survey is intended to gather your feedback regarding the perceived quality and effectiveness of different types of TA offered through the DOP OD2A TA program. Our goal is to understand which types of assistance best support your work. The data collected by this survey will help inform CDC decisions related to the types of support OD2A recipients.

The survey has been pre-populated to reflect the activities and other resources your organization has accessed during the last 18 months (Date to Date). The survey should reflect the organization—for example, if you did not attend a particular TA activity, but a colleague at your organization did participate, multiple respondents may contribute to the survey. The survey is designed to take approximately 13 minutes to complete.

INformed Consent

• Your participation is voluntary. You may refuse to answer any questions.

• ICF will maintain your responses in a secure system. ICF will have access to your contact information when you complete this survey. However, ICF will aggregate and de-identify responses when reporting to CDC. ICF will not link your name with your individual responses in any reports to CDC. ICF will maintain your responses in a secure manner.

• There are no right or wrong answers or ideas—we want to hear your experiences and opinions.

• There are no risks to you or your organization for participating in this survey. The survey data will be used to inform subsequent training and TA efforts.

• If you have questions about the survey or Institutional Review Board (IRB) approval, contact Megan Brooks at [email protected].

I have read the information above and agree to participate

• Agree, continue to the survey

Please indicate the OD2A recipient organization you are affiliated with:

Create drop down list of organizations

Alabama Department of Public Health	Georgia Department of Public Health	North Carolina Department of Health and Human Services
Alaska Department of Health & Social Services	Hamilton County General Health District (OH)	Ohio Department of Health
Allegheny County Health Department (PA)	Harris County (TX)	Oklahoma State Department of Health
Arizona Department of Health Services	Hawaii State Department of Health-Behavioral Health Administration	Oregon Health Authority, Public Health Division
Arkansas Department of Health	Health Research, Inc. (New York State Department of Health)	Pennsylvania Department of Health
Baltimore County Government (MD)	Idaho Department of Health and Welfare	Philadelphia Department of Public Health (PA)
California Department of Public Health	Illinois Department of Public Health	Puerto Rico Department of Health
City of Chicago, Department of Public Health	Indiana State Department of Health	Rhode Island Department of Health
Colorado Dept of Public Health & Environment	Iowa Department of Public Health	South Carolina Department of Health and Environmental Control
Commonwealth Healthcare Corporation (Northern Marianna Islands)	Kansas Department of Health and Environment	South Dakota Department of Health
Commonwealth of Massachusetts	Louisiana Office of Public Health	Southern Nevada Health District (Clark County, NV )
Connecticut Department of Public Health	Maine Department of Health and Human Services	Tennessee Department of Health
County of Riverside Department of Public Health (CA)	Maricopa County (AZ)	Thomes E Dobbs (Mississippi State Department of Health)
County of San Diego Health and Human Services Agency	Maryland Department of Health	University of Kentucky Research Foundation
Cuyahoga County Board of Health (OH)	Michigan Department of Health and Human Services	Utah Department of Health
Delaware Department of Health and Social Services	Minnesota Department of Health	Vermont State Agency of Human Services
District of Columbia Department of Health	Missouri Department of Health and Senior Services	Virginia Department of Health
Florida Department of Health	Montana Department of Public Health and Human Services	Washington State Department of Health
Florida Department of Health in Broward County (FL)	Nebraska Dept of Health and Human Services	West Virginia Department of Health and Human Resources
Florida Department of Health in Duval County	Nevada Department of Health and Human Services	Wisconsin Department of Health Services
Florida Department of Health, Palm Beach County (FL)	New Hampshire Department of Health and Human Services
Franklin County Board of Commissioners/Public Health (OH)	New Jersey Department of Health
Fund for Public Health in New York, Inc. (NYC Health)	New Mexico Department of Health

TA overall

Thinking about the TA you accessed in the last 18 months (e.g., webinars, one-on-one consultation, peer-to-peer, trainings, electronic resources, site visits), please rate your agreement with the following statements.

Dimensions to be assessed	Strongly disagree	Disagree	Neutral	Agree	Strongly agree	No opinion/not applicable
I understand the purpose of TA
Technology was used appropriately to support TA delivery
Lines of communication related to TA were clear
TA was provided in a timely manner
TA providers were responsive to my needs
TA supported implementation of our OD2A project
TA providers were professional and courteous
TA was aligned to my needs
TA was aligned with my organization’s capacity
It was helpful to hear about examples from other jurisdictions
I was aware of the technical assistance options

For each of the following strategies and activities, please indicate your agreement with the following statement: The TA I received helped me implement my work plan related to this strategy.

Strategy for Assessment	Strongly disagree	Disagree	Neutral	Agree	Strongly agree	No opinion/not applicable
Strategy 1. Collect and disseminate timeline emergency department data on suspected all drug, all opioid, heroin and all stimulant overdoses
Strategy 2. Collect and disseminate descriptions of drug overdose death circumstances using death certificates and medical examiner/coroner data
Strategy 3. Implement innovative surveillance to support NOFO interventions
Strategy 4. Prescription Drug Monitoring Programs
Strategy 5. Integration of State and Local Prevention and Response Efforts
Strategy 6. Establishing Linkages to Care
Strategy 7. Providers and Health Systems Support
Strategy 8. Partnerships with Public Safety and First responders
Strategy 9. Empowering Individuals
Strategy 10. Prevention Innovation Project

TA MODALITIES

Please rate the following TA modalities on their importance in helping achieve your OD2A work plan objectives: (Check one in each column).

Modality	Very Important	Important	Fairly Important	Slightly Important	Not at all Important	Not applicable
One-on-one virtual technical assistance
Conference calls
Webinars/ virtual training
Peer-to-peer exchanges
Site visits or in-person one-on-one technical assistance
In-person group training event
E-library (resources)
Helpdesk

TA Providers

Please rate the following TA providers on their importance in helping achieve your OD2A work plan objectives: (Check one in each column).

Modality	Very Important	Important	Fairly Important	Slightly Important	Not at all Important	Not applicable
CDC State Support Team
Other CDC experts
CDC’s partners (NACCHO, ASTHO, CSTE)
Other experts external to CDC

For each of the following strategies and activities, please indicate which modality and which provider was most helpful, and least helpful, to implement your workplan.

Strategy for Assessment	MOST helpful (Select one modality and one provider per strategy)	LEAST helpful (Select one modality and one provider per strategy)
Strategy 1. Collect and disseminate timeline emergency department data on suspected all drug, all opioid, heroin and all stimulant overdoses	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable
	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC
Strategy 2. Collect and disseminate descriptions of drug overdose death circumstances using death certificates and medical examiner/coroner data	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable
	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC
Strategy 3. Implement innovative surveillance to support NOFO interventions	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable
	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC
Strategy 4. Prescription Drug Monitoring Programs	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable
	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC
Strategy 5. Integration of State and Local Prevention and Response Efforts	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable
	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC
Strategy 6. Establishing Linkages to Care	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable
	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC
Strategy 7. Providers and Health Systems Support	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable
	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC
Strategy 8. Partnerships with Public Safety and First responders	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable
	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC
Strategy 9. Empowering Individuals	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable
	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC
Strategy 10. Prevention Innovation Project	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable	One-on-one virtual TA Conference calls Webinars/virtual training Peer to peer exchanges Site visits or in-person one-on-one technical assistance In-person group training events E-library Helpdesk Not applicable
	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC	CDC State Support Team Other CDC experts CDC’s partners (NACCHO, ASTHO, CSTE) Other experts external to CDC

What is your preferred way to receive technical assistance? [INSERT drop down with delivery modality]

CHALLENGES AND BARRIERS

Thinking about the last 18 months of OD2A support, please indicate if your jurisdiction experienced any of the following challenges accessing or participating in TA. [Drop down will be provided.]

Barriers and Challenges to Access and Participation

Topics were not relevant to my work

Scheduling issues

Lack of adequate notice for upcoming events

Competing priorities limited my TA participation

While the topics were relevant, the specific speakers were not interesting or appealing

No staff availability to attend

The TA was overly burdensome

Content level seemed too low for our organization

Content level seemed too high for our organization

Technology

Others

OPEN-ENDED FEEDBACK

1. Please tell us how the TA received has impacted your agency or organization.

2. What suggestions do you have for improving TA?

3. What additional TA needs do you or your organization have?